Following a meeting with the US FDA, clinical-stage biotech Dimerix has confirmed the appropriate primary endpoint for full ...

Morgan Rich, a living recipient, and her father, Lowell Ghosley, her kidney donor, highlight their advocacy for organ ...

The firm highlighted the potential for the company’s drug, Filspari, to address the significant unmet medical need in focal segmental glomerulosclerosis (FSGS). According to InvestingPro data ...

After being rushed to the emergency room with severe stomach pain, McConnell-Brent learned the problem was her kidneys and ...

After being rushed to the emergency room with severe stomach pain, McConnell-Brent learned the problem was her kidneys and ...

Doctors discovered that one of her kidneys was leaking too much protein during a routine check-up and decided to do ...

Dimerix Limited ( ($AU:DXB) ) has provided an announcement. Dimerix Limited announced significant progress in its quarterly activities report, ...

More than 100,000 people nationwide, including 5,000 in the Philadelphia area, are waiting for organ donations, a reality ...

ZyVersa is developing Cholesterol Efflux Mediator™ VAR 200 for treatment of chronic kidney diseases, initially focusing on FSGS as the lead. Plans for indication expansion include treatments ...

Scotiabank analyst Greg Harrison lowered the firm’s price target on Travere Therapeutics (TVTX) to $30 from $32 and keeps an Outperform rating ...